Profil
Robert J.
Gibson is Vice Chairman at Scopus Biopharma, Inc. since 2017.
Mr. Gibson is Co-Chairman at Hcfp.
Mr. Gibson is Executive Vice President at HCFP LLC.
Formerly, Mr. Gibson was an Analyst at Bear, Stearns & Co., Inc. Mr. Gibson was Vice President at CRT Capital Group LLC in 2009.
Mr. Gibson was Senior Vice President at First New England Capital.
Mr. Gibson was Senior Vice President at Balance Point Capital Partners LP.
Mr. Gibson completed undergraduate studies at Amherst College.
Postes actifs de Robert Gibson
| Sociétés | Poste | Début |
|---|---|---|
| SCOPUS BIOPHARMA INC. | Directeur/Membre du Conseil | 18/04/2017 |
HCFP LLC
HCFP LLC Financial ConglomeratesFinance Provides financial and accounting resources | Corporate Officer/Principal | - |
Hcfp/Capital Markets LLC | Président | - |
Anciens postes connus de Robert Gibson
| Sociétés | Poste | Fin |
|---|---|---|
CRT Capital Group LLC
CRT Capital Group LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 28/02/2009 |
Balance Point Capital Partners LP
Balance Point Capital Partners LP Investment ManagersFinance Acts as Private Equity Fund | Corporate Officer/Principal | - |
Bear, Stearns & Co., Inc.
Bear, Stearns & Co., Inc. Investment Banks/BrokersFinance Provides investment banking, securities trading and brokerage Services | Corporate Officer/Principal | - |
First New England Capital
First New England Capital Investment ManagersFinance First New England Capital (FNEC) invests in mezzanine and equity securities of middle market, later-stage companies across a variety of industries that have generated $10 million to $150 million of revenue and have demonstrated an ability to deliver strong operating performance and cash flow. They also consider investments in dynamic, fast-growing companies with a demonstrated ability to execute well-defined operating strategies. The firm seeks companies which have demonstrated a balance between sustainable growth and expense control. The firm prefers to invest in transactions that range in size from $2 million to $7 million. They may also make smaller investments in companies that have the potential for follow-on investment or larger investments in combination with other investment partners. Investments may be structured as current pay and/or payment-in-kind securities, preferred stock or common equity in conjunction with mezzanine capital. FNEC's capital is typically used to provide liquidity to founders and existing shareholders, to make acquisitions or finance organic growth. They will act as lead or participate as a member of larger syndicates. FNEC is often a minority investor. In most investments, FNEC requires board representation. | Analyste en capital-investissement | 24/05/2010 |
Formation de Robert Gibson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Bear, Stearns & Co., Inc.
Bear, Stearns & Co., Inc. Investment Banks/BrokersFinance Provides investment banking, securities trading and brokerage Services | Finance |
Balance Point Capital Partners LP
Balance Point Capital Partners LP Investment ManagersFinance Acts as Private Equity Fund | Finance |
CRT Capital Group LLC
CRT Capital Group LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Amherst College
Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
First New England Capital
First New England Capital Investment ManagersFinance First New England Capital (FNEC) invests in mezzanine and equity securities of middle market, later-stage companies across a variety of industries that have generated $10 million to $150 million of revenue and have demonstrated an ability to deliver strong operating performance and cash flow. They also consider investments in dynamic, fast-growing companies with a demonstrated ability to execute well-defined operating strategies. The firm seeks companies which have demonstrated a balance between sustainable growth and expense control. The firm prefers to invest in transactions that range in size from $2 million to $7 million. They may also make smaller investments in companies that have the potential for follow-on investment or larger investments in combination with other investment partners. Investments may be structured as current pay and/or payment-in-kind securities, preferred stock or common equity in conjunction with mezzanine capital. FNEC's capital is typically used to provide liquidity to founders and existing shareholders, to make acquisitions or finance organic growth. They will act as lead or participate as a member of larger syndicates. FNEC is often a minority investor. In most investments, FNEC requires board representation. | Finance |
HCFP LLC
HCFP LLC Financial ConglomeratesFinance Provides financial and accounting resources | Finance |
Scopus Biopharma, Inc.
Scopus Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company develops transformational therapeutics for serious diseases | Health Technology |
Hcfp/Capital Markets LLC | Finance |
















